Physician
Mary Bird Perkins Cancer Center
Mary Bird Perkins Cancer Center was paid $8.45M by Medicaid between Jan 2018 and Dec 2024, across 62 billing codes. Its largest line is 77014, — 38% of everything it billed.
33Billing provider infoMARY BIRD PERKINS CANCER CENTER
BATON ROUGE, LA 70809
BATON ROUGE, LA 70809
33aNPI1295833580assigned 09/20/2006
33bProvider typeRadiation Oncology Physician
28Total paid$8.45M
24GClaims164,068
24DCodes billed62
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Radiation Oncology Physician providers in Louisiana
Rank by total paid#1 of 10
Median peer was paid$113K
This provider vs. median75×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,332 | $1.05M | |
| 2019 | 11,908 | $977K | |
| 2020 | 11,840 | $893K | |
| 2021 | 14,448 | $1.13M | |
| 2022 | 32,747 | $1.40M | |
| 2023 | 44,464 | $1.73M | |
| 2024incomplete | 36,329 | $1.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 77014 | 38% | 54,197 | 16,181 | $3.21M | |
| 77386 | 31% | 15,287 | 4,994 | $2.61M | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 8.9% | 20,880 | 12,194 | $756K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.5% | 13,554 | 10,784 | $383K |
| 77427 | 3.5% | 4,521 | 1,726 | $292K | |
| 77336 | 2.6% | 6,910 | 3,975 | $217K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 1.9% | 1,679 | 790 | $157K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.8% | 5,506 | 2,263 | $154K |
| 77412 | 1.2% | 1,149 | 402 | $104K | |
| 77334 | <1% | 863 | 609 | $81K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 3,743 | 3,204 | $69K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 812 | 589 | $45K |
50 more codes
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | <1% | 3,300 | $37K |
| 77385 | <1% | 191 | $36K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 1,723 | $33K |
| 77301 | <1% | 85 | $32K | |
| 99205 | Prolong outpt/office vis | <1% | 495 | $31K |
| 77290 | <1% | 203 | $28K | |
| 77300 | <1% | 354 | $22K | |
| 80053 | Comprehensive metabolic panel | <1% | 3,565 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,817 | $17K |
| 77263 | <1% | 165 | $11K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 156 | $11K |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,924 | $9K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 182 | $9K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 125 | $7K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 199 | $7K |
| 77338 | <1% | 42 | $7K | |
| 99223 | Prolong inpt eval add15 m | <1% | 121 | $6K |
| 82728 | <1% | 639 | $5K | |
| 99195 | <1% | 124 | $5K | |
| 96417 | <1% | 191 | $4K | |
| 83550 | <1% | 593 | $3K | |
| 82378 | <1% | 273 | $3K | |
| 80050 | General health panel | <1% | 92 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 380 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 711 | $2K |
| 83540 | <1% | 594 | $2K | |
| 83615 | <1% | 471 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 86 | $1K |
| 96415 | <1% | 100 | $1K | |
| 96411 | <1% | 59 | $1K | |
| 96416 | <1% | 28 | $1K | |
| 83735 | <1% | 152 | $725.66 | |
| 96367 | <1% | 903 | $716.24 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,748 | $650.86 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,964 | $579.38 |
| 84153 | <1% | 76 | $536.19 | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 75 | $513.19 |
| 96402 | <1% | 65 | $499.17 | |
| 82607 | <1% | 59 | $421.21 | |
| 84403 | <1% | 31 | $403.49 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 663 | $355.19 |
| 77370 | <1% | 16 | $329.68 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 415 | $197.03 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 444 | $188.17 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 158 | $66.52 |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 29 | $42.71 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 26 | $20.34 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 47 | $16.44 |
| 96523 | <1% | 89 | $9.35 | |
| J3490 | Unclassified drugs | <1% | 19 | $3.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKRAFT, JACOB (DECISION SUPPORT MANAGER)
| Provider | Location | Paid |
|---|---|---|
| ST. Elizabeth-Mary Bird Perkins Cancer Center, L.L.C. | Gonzales, LA | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.